ChromaDex

Company Description

Niagen Bioscience, Inc. is a global bioscience company focused on research related to nicotinamide adenine dinucleotide (NAD+). The company operates in the dietary supplement and ingredient industries. It supplies ingredients to manufacturers of consumer products and offers NAD+ test kits. In the last fiscal year, the company had a market cap of $876 million, profits of $62 million, and revenue of $100 million, with 104 employees.

Analysis

ANALYSIS: With an Obermatt 360° View of 71 (better than 71% compared with alternatives), overall professional sentiment and financial characteristics for the stock ChromaDex are above average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for ChromaDex. The consolidated Growth Rank has a good rank of 81, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 81% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 84, which means that professional investors are more optimistic about the stock than for 84% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 1, which means that the share price of ChromaDex is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 99% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 48, which means that the company has a financing structure that is riskier than those of 52% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

Country

USA

Industry Life Sciences Tools & Services

Size X-Small

Website chromadex.comdefault.aspx

Index

NASDAQ

Add to Watchlist

See Similar Stocks

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.